Transfusion

Article	Citations
P‐BB‐35 | Evaluating Thrombocytosis in Apheresis Platelet Donors	71
P‐TS‐45 | Improving Blood Transfusion Ordering for Patients with Sickle Cell Disease	60
P‐BB‐53 | Is Average Donor Platelet Count Equivalent to Manufacturer's Recommended Average?	51
P‐BT‐13 | Hematology Analyzer Evaluation for Cellular Therapies	44
P‐TS‐84 | The Incidence of Reported Transfusion Related Acute Lung Injury (TRALI) by Blood Component: A Systematic Review and Meta‐Analysis	35
OA3‐AM23‐SN‐18 | Routine RBC Reduction of Bone Marrow Products Before Cryopreservation Results in Acceptable Cell Recovery and Viability and does not Affect Engraftment	33
P‐TS‐11 | An Unusual Case of Transfusion Related Acute Lung Injury	30
P‐BB‐55 | Lower Cost of Monitoring Leukocyte Reduction QC of Platelets with No Sampling	29
P‐QU‐4 | Impact of Enhancing Criteria for Recognition of Transfusion Reactions	28
Masthead and Table of Contents	27
Cover	27
	27
Massive transfusion protocol reactivation as a novel marker of physician team under‐triage after injury	25
How do I transfer liquid nitrogen freezers to a new home safely?	25
Hematopoietic progenitor cell count as a potential quantitative marker in apheresis products during allogeneic stem cell transplantation	25
Effective peripheral blood stem cell collection in a 4.6‐kg child	24
Complement‐mediated hemolysis persists year round in patients with cold agglutinin disease	23
Relationship between B‐cell epitope structural properties and the immunogenicity of blood group antigens: Outlier properties of the Kell K1 antigen	23
Vesiculation in irradiated and cation‐leaky‐stored red blood cells	22
The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses	22
Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee	22
Regulatory T cells: A review of manufacturing and clinical utility	21
Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada	21
A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system	21
Abstract Awards	21

Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups	20
Masthead and Table of Contents	20
Who donates? Patterns of blood donation and donor characteristics at a university‐affiliated hospital‐based donor center	20
Associations between blood donor sex and age, and outcomes of transfused newborn infants	19
Plasma exchange using peripheral arterial and venous access in the pediatric intensive care unit	18
Cover	18
Life‐threatening hemorrhage as defined by the critical administration threshold in nontraumatic critical bleeding: A descriptive observational study	18
Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re‐emergence of syphilis and HIV pre‐exposure prophylaxis use	17
Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel	17
Hyperbaric treatment of platelets extends in vitro storage to 14 days	17
How did we reform our out of control massive transfusion protocol program?	16
The senescent antigen hypothesis of RBC evanescence: 50 years of correlation without causation	16
The first two years of the use of low titer group O whole blood during French Military overseas operations: A retrospective study	16
Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations	16
Effect of major trauma on the expected number of births in Finnish women: A nationwide population‐based public data and register analysis	16
Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters	16
P‐TS‐17 | Characterizing the Transfusion Continuum in a Low‐Resource Referral Hospital in Kenya: Developing a Protocol for Emergency Transfusions	16
Evaluation of platelets componentized with the Reveos Automated Blood Processing System and stored for 7 days at room temperature in a non‐Di(2‐ethylhexyl) phthalate (DEHP) platelet pooling set	16
Climate change and parasitic risk to the blood supply	16
Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial	15
Administration of blood products in the prehospital setting can decrease trauma patient mortality	15
Hemostatics in patients with inhibited coagulation—A viscoelastic in‐vitro analysis	15
Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium	15
Transfusion‐associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow‐up. A prospective cohort study	15
HIV incidence in US first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment	14
Identification of a novel c.259G > T mutation in the ABO*B.01 allele giving rise to a B3 phenotype	14
Author Index	14
Subject Index	14
P‐TS‐29 | Effect of Donor and Recipient Characteristics on Hemoglobin Increments in Intensive Care Unit Patients Receiving Red Blood Cell Transfusion	14
Incorrect blood typing and mis‐transfusion due to low‐titer group O whole blood resuscitation	14
Abstract Awards	14
P‐BB‐19 | Building the Bridge for Prehospital Blood Transfusion: A Standardized Approach from a Blood Center	14
P‐IT‐10 | Improving Donor Experience and Streamlining Blood Donation Process Through a Web‐Based Software Application: A Beta Analysis	13
P‐IG‐3 | Prevalence of the Mia Antigen in a Multi‐Ethnic Donor Population	13
P‐TS‐14 | Blood Utilization Trends Among Inpatient US Medicare Beneficiaries Ages 65 and Older, During 2007–2021	13
P‐CB‐5 | CMV Coinfection Enhances RBC Alloimmunization Via a Novel, Type I Interferon‐Independent Mechanism	13
P‐BB‐5 | A New Thermoregulated Container System for Cold Processing of Whole Blood Donations in Extreme Climate Conditions	13
P‐BB‐11 | Analysis of Donor Moderate and Severe Vasovagal Reactions During Donation on the Alyx Collection Device	13
P‐CB‐15 | Lu/BCAM, Lw/ICAM in Polycythemia Vera	13
P‐ED‐5 | Providing Advanced Blood Banking Education to Sub‐Saharan Africa: A Project Between a US University and a University in Rwanda	13
P‐TS‐88 | To Wash or Not to Wash: Managing Transfusion Expectations in a Transplant Patient with Severe IgA Deficiency	13
P‐IS‐5 | Impact of Instrument Uptime Facilitated by Remote Diagnostics in Trauma Centers	13
Masthead and Table of Contents	12
A new allele with 303 base pairs insertion in B3GALT1 gene identified in an individual with P1k phenotype	12
Perceived risk of HIV transmission by blood transfusion among gay, bisexual, and other men who have sex with men (gbMSM) in Australia	12
Missense RHD single nucleotide variants induce weakened D antigen expression by altering splicing and/or protein expression	12
Aberrant buffy coat formation during leukodepletion for hyperleukocytosis in a case of primary myelofibrosis‐transforming acute myeloid leukemia	12
OA4‐AM23‐ST‐13 | Risk Factors for Active Syphilis Infections in US Blood Donors in the Period 2020–2022	12
Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population‐based study	12
Reply	12

Cryoprecipitate contaminated with Cupriavidus pauculus: A rare cautionary case report	12
P‐MG‐1 | Development of A Career Progression Framework for a Donor Screening Laboratory	12
Use of KEL‐1 negative red blood cells for emergency release	12
Identification of a novel c.77T>G mutation on the ABO*B.01 allele associated with a B subtype	12
Reevaluation of the medical necessity of washed red blood cell transfusion in chronically transfused adults	12
Cold‐stored platelets are effective in an in vitro model of massive transfusion protocol assessed by rotational thromboelastometry	12
Dark brown plasma in healthy blood donor: Art of visual inspection in era of automation	12
P‐TS‐31 | Evaluation of Potassium Levels in Non‐irradiated and Irradiated Red Cells Units	12
NM_000148.4(FUT1):c.[229C>T;302C>T]with 2 missense variations in theFUT1gene associated with a para‐Bombay phenotype	12
Fatal hemolytic disease of the newborn due to anti‐B Isohemagglutinin: An unfamiliar presentation of a familiar disease	11
	11
Production of recombinant humanized monoclonal anti‐human neutrophil antigen (HNA) antibodies with potential applicability as standard antibodies	11
Comparison of manual titrations to automated microplate and gel titration assays used in the screening of blood donors for production of Low‐Titer O Whole Blood	11
Use of convalescent plasma inCOVID‐19 patients with immunosuppression	11
Low rate of RNAemia in blood donations collected during the first wave of COVID‐19 in France	11
Impact of elevated direct factor Xa inhibitor plasma levels on perioperative blood loss in patients undergoing urgent surgery	11
A novel immunocomplex capture fluorescence assay (ICFA) using fluorescent beads and transfected cells for specific identification of human neutrophil antigen (HNA)‐1a and ‐1b ant	11
A new missense variant in exon 7 of the ABO gene, c.662G>A, in a family with Bw phenotype	11
Blood component use and injury characteristics of acute trauma patients arriving from the scene of injury or as transfers to a large, mature US Level 1 trauma center serving a large, geogra	11
Blood group antigens and antibodies in East Asia and their impact on transfusion practice	11
Osmotic hemolysis is a donor‐specific feature of red blood cells under various storage conditions and genetic backgrounds	10
Use of prehospital transfusion by French emergency medical services: A national survey	10
Systematic review for the serological testing for cold agglutinins: The BEST collaborative study	10
Insulin resistance, overweight, and obesity in apheresis donors: A call to reevaluate their eligibility—A prospective cohort study	10
Durable remission of thrombotic thrombocytopenic purpura in the setting of pembrolizumab therapy	10
Subclavian steal syndrome masquerading as a hypotensive transfusion reaction	10
A monthly roundup of key articles in other journals	10
From pandemic to participation: A two‐year follow‐up of blood donors in the Netherlands who registered during the first wave of the COVID‐19 pandemic	10
CONTINUING MEDICAL EDUCATION	10
Erratum	10
Prolonged storage of purified granulocyte concentrates: Introduction of a new purification method	10
Four novelABO*AWalleles associated with weak antigen expression	10
Severe neonatal thrombocytopenia due to anti‐HPA‐4b alloantibodies: Third report described in a Caucasian mother	10
First report of transfusing low‐titer cold‐stored type O whole blood to an extremely‐low‐birth‐weight neonate after acute blood loss	10
“Are my blood products coming?”: Implementation of a novel blood product tracker in the electronic health record system	10
Risk of transfusion‐transmitted Babesia microti in Canada	10
Rejuvenated and safe: Freeze‐dried plasma for the 21st century	10
The effect of the SARS‐CoV‐2 pandemic and civil unrest on massive transfusion protocol activations in Minneapolis 2020	10
Mysterious clumping in a cell therapy product	10
OA1‐AM23‐ST‐24 | Cost Savings of Strategic Plan for Distribution of Cold Stored Platelets	9
	9
P‐BB‐56 | Mitigation Steps to Reduce Platelet Discard Rates due to Aggregates	9
When should RhD‐negative recipients be spared the transfusion of DEL red cells to avoid anti‐D alloimmunization?	9
Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD‐positive blood products in trauma	9
Component modifications and acute transfusion reactions: Important then, more to learn now	9
Fear is associated with attrition of first‐time whole blood donors: A longitudinal examination of donor confidence and attitude as potential mediators	9
Commentary on the 1976 Transfusion paper by Aster, Becker, and Filip	9
Cover Image	9
Hypertension and encephalopathy in a pediatric patient following red blood cell transfusion	9
P‐BB‐62 | Post‐collection Processing of Packed RBCs from Pig	9
Cover	9
E‐learning in transfusion medicine: A scoping review	9
The novel c.634+4A>G splicing variant inRHCEresults in weak C and e antigen expression in a pregnant woman originated from Japan	9
Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population‐based study	9
A novelSNVon a previously reported hybridRHCEbackground is responsible for an Rh haplotype potentially involved in the generation of an Rh null phenotype	9
Syphilis‐positive and false‐positive trends among US blood donors, 2013–2023	9
An insertion/deletion polymorphism in the KLF1 gene resulting in an In(Lu) phenotype	9
Sexual risk behavior questions: Understanding and mitigating donor discomfort	9
P‐TS‐27 | Do We Send It Out or Run Selected Cells? A Statistical Evaluation of Panel Efficiency	9
P‐BB‐16 | Assessment of Point‐of‐Care, Rapid Diagnostic Tests for Transfusion Transmissible Infections for a Walking Blood Bank	9
Identification of a novel nonfunctional FUT1 allele with 967delG in a Chinese para‐Bombay phenotype individual	9
The operational and financial impact of adding anaerobic screening of platelets	9
Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study	9
Anti‐D alloimmunization in Rh(D) negative adults with severe traumatic injury	9
Table of Contents	9
Plasma transfusion–transmission of Zika virus in mice and macaques	9
Prevalence and clinical implications of heightened plastic chemical exposure in pediatric patients undergoing cardiopulmonary bypass	9
OA3‐AM23‐SN‐22 | “You Don't Know Where [the Blood] Goes”: Findings from Focus Group Discussions with Black/African American Donors and Non‐donors in Southeastern United States	9
OA3‐AM23‐MN‐12 | Residual Leukocytes in Leukoreduced Platelet Products are Required for Humoral Alloimmunization and Platelet Refractoriness in Mice	9
Implementation of national blood conservation recommendations at an adult sickle cell center	8
Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens	8
	8
P‐TS‐8 | An Evaluation of Product Usage and Wastage After Implementation of Low‐Titer Group O Whole Blood Products Issued for Patients Under Massive Transfusion Protocol	8
P‐IG‐20 | Evaluation of High‐Density DNA Array Genotyping on African Ancestry Samples	8
Blood donor return behavior in South Africa and the United States before and during the COVID‐19 pandemic	8
P‐TS‐60 | Neutrophil Antigen Antibodies Affect Engraftment and Secondary Graft Failure in Hematopoietic Progenitor	8
Balancing non‐discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior	8
P‐TS‐35 | Group O Red Blood Cell Utilization in Group A recipients with Neonatal Congenital Diaphragmatic Hernia Surgical Repair: A Patient Blood Management Opportunity	8
Thank You to Our Reviewers	8
P‐BB‐51 | Increasing Blood Diversity: How Blood Center Websites Tackle Critical Blood Shortages for Sickle Cell Patients Through Recruitment of African‐American Donors	8

Why do US source plasma donors stop donating?	8
Modeling hemoglobin levels of patients chronically transfused with red blood cells	8
Hepatitis A virus (HAV) RNA detection in Polish blood donors and likely transmissions through blood components during the 2017–2019 epidemic	8
Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden	8
Mouse background genetics in biomedical research: The devil's in the details	8
P‐QU‐8 | Using Quality Improvement to Improve Nurse Completion of Transfusion Orders	8
P‐BT‐18 | Plerixafor‐based Mobilization and Collection of Hematopoietic Stem Cells in Sickle Cell Disease Four Patients in India	8
P‐TS‐61 | Outpatient Transfusions and Transfusion‐Associated Circulatory Overload (TACO) Among US Medicare Beneficiaries, Ages 65 and Older, During 2016‐2022	8
P‐QU‐9 | Validation: Average Number of Correlations Per Assay	8
Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat	8
Intentional transfusion of expired blood products	8
Critical value reporting of direct antiglobulin testing in newborns: No discernable pattern	8
P‐BB‐48 | Improving Platelet Collection Efficiency with Data Management	8
A narrative review: Resuscitation of older adults with hemorrhagic shock	8
Evolving patterns of first blood product use in trauma in the era of hemorrhage control resuscitation	8
Masthead and Table of Contents	8
A monthly roundup of key articles in other journals	8
Transfusion of ABO‐group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patients	8
P‐PH‐8 | The Evolution and Interpretation of Seroprevalence of SARS‐CoV‐2 Antibodies Among Blood Donors from the Beta to Omicron Variant Driven Waves	8
P‐TS‐86 | There's a Form for That	8
P‐CB‐20 | Preliminary Characterization of Extracellular Vesicles in Intraoperative Cell Salvaged Blood	8
P‐TS‐79 | Severe Acute Hemolytic Transfusion Reaction in a Pregnant Patient Due to Rare Anti‐Vel	8
	8
Validation of new, gender‐neutral questions on recent sexual behaviors among plasma donors and men who have sex with men	8
Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy	8
Erratum	8
Medicinal leech in the blood bank laboratory plumbing	8
Measuring the effectiveness of online search ads on blood donor recruitment and donation	8
2023 Oral Abstract Presentation Schedule	7
P‐TS‐81 | Successful Surgical Management of Patient with Anti‐Jk3	7
P‐ED‐1 | Development of Competency Assessment Tracker and Training Dashboard Smartsheets	7
P‐QU‐7 | Performance Verification of Apheresis Devices in Pediatric Cell Therapy Collection	7
The safety of ABO minor incompatible platelets transfusions using a rapid infuser	7
Masthead and Table of Contents	7
P‐CB‐22 | Reduction of Anti‐A and Anti‐B Isoagglutinin Titers of Group O Platelet Units with an ABO Antibody Immune Adsorption Column	7
P‐TS‐15 | Building Downtime Transfusion Label into Routine Labeling Process	7
P‐PB‐8 | Blood Components Utilization in Pediatric Cardiac Surgeries at a Tertiary Care Freestanding Children's Hospital in India	7
OA4‐AM23‐MN‐06 | The Blood System in Ukraine: Experience in Martial Law Conditions	7
P‐TS‐94 | Trial of INTERCEPT Fibrinogen Complex to Support Massive Transfusion Protocols	7
OA2‐AM23‐MN‐19 | Genetic Loci Containing Immunoregulatory IFIT Genes are Associated with RBC Alloimmunization in an Outbred Mouse Population	7
Donors with repeated blood product discards for filtration problems, clots or hemolysis: Causes and follow‐up	7
Plasma cell‐directed therapy strategies in immune‐mediated thrombotic thrombocytopenic purpura (iTTP)	7
Blood, sweat, and fears: Athletes' perceptions of blood donation and engagement in physical activity	7
How do we achieve blinding in modern electronic and paper medical records during the conduct of transfusion trials?	7
OA3‐AM23‐TU‐13 | Platelet Transfusion in Critical Care: A New Method to Analyze Transfusion Practice Based on Decision Time Intervals	7
OA4‐AM23‐MN‐13 | Post‐Transfusion Laboratory Parameters of Patients Transfused with Low Volume Red Blood Cell Products	7
P‐PH‐6 | Regulating Blood Systems in the WHO Eastern Mediterranean Region	7
OA1‐AM23‐ST‐23 | Associations Between Platelet Aggregation in Apheresis Units, COVID‐19 Vaccination, SARS‐CoV‐2 Infection Status, and Antibody Levels	7
P‐IG‐11 | Apparent RHCE Phenotype Discrepancy in a Mother and Child Due to a Shared RHCE*CE‐D(3‐9)‐CE Allele	7
Analysis of outcomes of single‐unit cord blood transplantation with umbilical cord blood units processed with two different red blood cell sedimentation reagents	7
Weak or discrepant RhD phenotypes: Laboratory management strategies for local patient populations	7
A monthly roundup of key articles in other journals	7
P‐BT‐5 | Convalescent Plasma (CP) Program for COVID‐19 in Singapore	7
P‐BT‐2 | A Machine Learning Model for Unstimulated T‐Cell Collection in the Cell Therapy Starting Materials for CAR‐T‐Cell Manufacturing	7
Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA‐02 and	6
Cover	6
Red blood cell volume, but not platelet or plasma volume is associated with mortality in neonatal ECMO	6
A novel RHD allele, RHD c.56C>G (p.Thr19Arg), with Del phenotype identified in a Chinese family	6
Transfusion‐transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange	6
Regulatory challenges of convalescent plasma collection during the evolving stages of COVID‐19 pandemic in the United States	6
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study	6
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE	6
Evidence that donors with variant RH genotypes are associated with unexpected Rh antibodies	6
O, wind, if winter comes … will symptoms be far behind?	6
RHCE null allele causing D‐‐ phenotype in a Latin‐American blood donor	6
Presence of Gram‐negative bacteria and Staphylococcus aureus on the skin of blood donors in the Democratic Republic of the Congo	6
Optimizing interpretation of survival studies of fresh and aged transfused biotin‐labeled RBCs	6
Patterns and determinants of blood transfusion in intensive care in Sweden between 2010 and 2018: A nationwide, retrospective cohort study	6
Real‐world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single‐center with homogeneous treatment experience	6
Patient Blood Management: Why We Need to Change	6
Hyperviscosity syndrome in Waldenström Macroglobulinemia	6
Cover	6
Masthead and Table of Contents	6
Solvent/detergent treated pooled human plasma can decrease the recurrence of allergic transfusion reactions in pediatric, adolescent, and young adult patients	6
Continuing Medical Education	6
c.5del mutation on the ABO*B.01 allele responsible for Bx phenotype	6
Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV‐2 neutralizing antibodies in hospitalized patients with COVID‐19	6
Prediction of fetal blood group antigens from maternal plasma using Ion AmpliSeq HD technology	6
Beyond fear: A longitudinal investigation of emotions and risk of a vasovagal reaction in first‐time whole‐blood donors	6
What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation	6
Allergic reaction to psoralen‐treated platelets: Real or coincidence?	6
Screening for Zika virus in US armed services blood program donors: An opportunity to compare emerging infectious disease risk between the general US population and military donors	6
Supporting the expansion of organ transplant: Transfusion services handle the details	6
Successful autologous hematopoietic stem cell transplants using Salmonella positive products collected from asymptomatic donors	6
	6
A monthly roundup of key articles in other journals	6
Masthead and Table of Contents	6
Safety and tolerability of solvent/detergent‐treated plasma for pediatric patients requiring therapeutic plasma exchange: An open‐label, multicenter, postmarketing study	6
Infectious disease agents and their potential threat to transfusion safety (an update to the 2009 Transfusion supplement)	6
Masthead and Table of Contents	6
CMV screening of group‐specific orders—good stewardship of the blood supply	6
P‐TS‐5 | Adverse Event Outcomes of 6‐Day‐Stored Pathogen‐Reduced Platelet Transfusion	6
Mobile blood depots in ground ambulances in compliance with French legislation: A feasibility study	6
Learning transfusion medicine through scoring objective structured clinical examination	6
Post‐exchange neutrophil count, but not post‐hematocrit, predicts endogenous erythropoiesis in patients with sickle cell disease undergoing chronic red cell exchange	6